Literature DB >> 25823611

Generation of Natural Killer Cell Memory during Viral Infection.

Timothy E O'Sullivan1, Joseph C Sun.   

Abstract

Immunological memory is classically regarded as an attribute of antigen-specific T and B lymphocytes of the adaptive immune system. Cells of the innate immune system, including natural killer (NK) cells, have been considered short-lived cytolytic cells that can rapidly respond against pathogens in an antigen-independent manner and then die off. However, NK cells have recently been described to possess traits of adaptive immunity, such as clonal expansion after viral antigen exposure to generate long-lived memory cells. In this review, we will discuss the current evidence for viral-induced NK cell memory in both mice and humans.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 25823611      PMCID: PMC4581887          DOI: 10.1159/000375494

Source DB:  PubMed          Journal:  J Innate Immun        ISSN: 1662-811X            Impact factor:   7.349


  49 in total

1.  Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells.

Authors:  J M Grayson; A J Zajac; J D Altman; R Ahmed
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

2.  Vital involvement of a natural killer cell activation receptor in resistance to viral infection.

Authors:  M G Brown; A O Dokun; J W Heusel; H R Smith; D L Beckman; E A Blattenberger; C E Dubbelde; L R Stone; A A Scalzo; W M Yokoyama
Journal:  Science       Date:  2001-05-04       Impact factor: 47.728

3.  IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Authors:  Alexander Rölle; Julia Pollmann; Eva-Maria Ewen; Vu Thuy Khanh Le; Anne Halenius; Hartmut Hengel; Adelheid Cerwenka
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

Review 4.  Human natural killer cell deficiencies and susceptibility to infection.

Authors:  Jordan S Orange
Journal:  Microbes Infect       Date:  2002-12       Impact factor: 2.700

5.  Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions.

Authors:  Martin R Goodier; Matthew J White; Alansana Darboe; Carolyn M Nielsen; Adriana Goncalves; Christian Bottomley; Sophie E Moore; Eleanor M Riley
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

6.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

7.  Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H.

Authors:  K A Daniels; G Devora; W C Lai; C L O'Donnell; M Bennett; R M Welsh
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

8.  Autophagy is a critical regulator of memory CD8(+) T cell formation.

Authors:  Daniel J Puleston; Hanlin Zhang; Timothy J Powell; Elina Lipina; Stuart Sims; Isabel Panse; Alexander S Watson; Vincenzo Cerundolo; Alain Rm Townsend; Paul Klenerman; Anna Katharina Simon
Journal:  Elife       Date:  2014-11-11       Impact factor: 8.140

9.  Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells.

Authors:  Merlin Luetke-Eversloh; Quirin Hammer; Pawel Durek; Karl Nordström; Gilles Gasparoni; Matthias Pink; Alf Hamann; Jörn Walter; Hyun-Dong Chang; Jun Dong; Chiara Romagnani
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823

10.  Cytomegalovirus generates long-lived antigen-specific NK cells with diminished bystander activation to heterologous infection.

Authors:  Gundula Min-Oo; Lewis L Lanier
Journal:  J Exp Med       Date:  2014-11-24       Impact factor: 14.307

View more
  8 in total

1.  The characteristics of NK cells in Schistosoma japonicum-infected mouse spleens.

Authors:  Lu Li; Hefei Cha; Xiuxue Yu; Hongyan Xie; Changyou Wu; Nuo Dong; Jun Huang
Journal:  Parasitol Res       Date:  2015-08-29       Impact factor: 2.289

Review 2.  Trial Watch: Adoptively transferred cells for anticancer immunotherapy.

Authors:  Carole Fournier; François Martin; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi; Lionel Apetoh
Journal:  Oncoimmunology       Date:  2017-08-11       Impact factor: 8.110

Review 3.  Adaptive NK cell responses in HIV/SIV infections: A roadmap to cell-based therapeutics?

Authors:  Daniel R Ram; Cordelia Manickam; Olivier Lucar; Spandan V Shah; R Keith Reeves
Journal:  J Leukoc Biol       Date:  2019-02-07       Impact factor: 4.962

4.  Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.

Authors:  Stephen R Goding; Shaohong Yu; Lisa M Bailey; Michael T Lotze; Per H Basse
Journal:  Clin Immunol       Date:  2016-07-01       Impact factor: 3.969

5.  Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

Authors:  Suresh B Boppana; William J Britt
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections.

Authors:  Cordelia Manickam; Spandan V Shah; Junsuke Nohara; Guido Ferrari; R Keith Reeves
Journal:  Front Immunol       Date:  2019-05-22       Impact factor: 7.561

Review 7.  Memory of Natural Killer Cells: A New Chance against Mycobacterium tuberculosis?

Authors:  José Alberto Choreño Parra; Nayeli Martínez Zúñiga; Luis Antonio Jiménez Zamudio; Luis Armando Jiménez Álvarez; Citlaltepetl Salinas Lara; Joaquín Zúñiga
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

8.  TLR3 Modulates the Response of NK Cells against Schistosoma japonicum.

Authors:  Jiale Qu; Lu Li; Hongyan Xie; Xiaona Zhang; Quan Yang; Huaina Qiu; Yuanfa Feng; Chenxi Jin; Nuo Dong; Jun Huang
Journal:  J Immunol Res       Date:  2018-08-30       Impact factor: 4.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.